Corrigendum to "Upregulation of tripeptidyl-peptidase 1 by 3-hydroxy-(2,2)-dimethyl butyrate, a brain endogenous ligand of PPARα: Implications for late-infantile Batten disease therapy" [Neurobiology of Disease 127 (2019) 362-373].

Sudipta Chakrabarti Sujyoti Chandra Avik Roy Madhuchhanda Kundu Kalipada Pahan

Neurobiol Dis

Department of Neurological Sciences, Rush University Medical Center, Chicago, USA; Division of Research and Development, Jesse Brown Veterans Affairs Medical Center, Chicago, USA. Electronic address:

Published: May 2024

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.nbd.2024.106479	DOI Listing

Publication Analysis

Top Keywords

corrigendum "upregulation

"upregulation tripeptidyl-peptidase

tripeptidyl-peptidase 3-hydroxy-22-dimethyl

3-hydroxy-22-dimethyl butyrate

butyrate brain

brain endogenous

endogenous ligand

ligand pparα

pparα implications

implications late-infantile

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!